124 related articles for article (PubMed ID: 2778490)
21. Chemiluminescence response of human natural killer cells. I. The relationship between target cell binding, chemiluminescence, and cytolysis.
Helfand SL; Werkmeister J; Roder JC
J Exp Med; 1982 Aug; 156(2):492-505. PubMed ID: 6178787
[TBL] [Abstract][Full Text] [Related]
22. Cultured brain endothelium inhibits the cytocidal action of natural killer cells on glioma.
Rozental JM; Kaminska GM; Kaminski MJ
J Neurooncol; 1989 May; 7(1):65-9. PubMed ID: 2754457
[TBL] [Abstract][Full Text] [Related]
23. Lymphokine (IL-2 and TNF-alpha) mediated cytolytic activity against glioma cells in vitro.
Herrmann HD; Köppen JA; Kühl N; Raschdorf C; Westphal M
Cancer Treat Rev; 1989 Jun; 16 Suppl A():21-7. PubMed ID: 2788505
[No Abstract] [Full Text] [Related]
24. [Activity of the natural killer cells in the peripheral blood of patients with brain tumors].
Lisianyĭ NI; Markova OV; Zhmareva EN
Eksp Onkol; 1988; 10(3):57-9. PubMed ID: 3409835
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells.
Ciaglia E; Torelli G; Pisanti S; Picardi P; D'Alessandro A; Laezza C; Malfitano AM; Fiore D; Pagano Zottola AC; Proto MC; Catapano G; Gazzerro P; Bifulco M
Oncotarget; 2015 Jun; 6(17):15464-81. PubMed ID: 26008966
[TBL] [Abstract][Full Text] [Related]
26. Experimental appraisal of the lack of antitumor natural killer cell-mediated immunosurveillance in response to lymphomas growing in the mouse brain.
Yamasaki T; Moritake K; Klein G
J Neurosurg; 2003 Mar; 98(3):599-606. PubMed ID: 12650434
[TBL] [Abstract][Full Text] [Related]
27. Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocytes, but not by lymphokine-activated killer cells.
Holladay FP; Heitz T; Wood GW
J Neurosurg; 1992 Nov; 77(5):757-62. PubMed ID: 1403119
[TBL] [Abstract][Full Text] [Related]
28. Effect of LAK cells against three-dimensional tumor tissue. In vitro study using multi-cellular human glioma spheroids as targets.
Jääskeläinen J; Kalliomäki P; Paetau A; Timonen T
J Immunol; 1989 Feb; 142(3):1036-45. PubMed ID: 2783598
[TBL] [Abstract][Full Text] [Related]
29. Proteomic comparison of 3D and 2D glioma models reveals increased HLA-E expression in 3D models is associated with resistance to NK cell-mediated cytotoxicity.
He W; Kuang Y; Xing X; Simpson RJ; Huang H; Yang T; Chen J; Yang L; Liu E; He W; Gu J
J Proteome Res; 2014 May; 13(5):2272-81. PubMed ID: 24742303
[TBL] [Abstract][Full Text] [Related]
30. Autologous natural killer cell therapy for human recurrent malignant glioma.
Ishikawa E; Tsuboi K; Saijo K; Harada H; Takano S; Nose T; Ohno T
Anticancer Res; 2004; 24(3b):1861-71. PubMed ID: 15274367
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory infiltrates and natural killer cell presence in human brain tumors.
Stevens A; Klöter I; Roggendorf W
Cancer; 1988 Feb; 61(4):738-43. PubMed ID: 3338036
[TBL] [Abstract][Full Text] [Related]
32. Cellular and antigenic properties of cultured normal and fetal brain and glioma cells.
Shen AL; Hu CP; Hsia RC; Tsai LM; Lee LS; Chang CM
J Neuroimmunol; 1985 May; 8(2-3):141-51. PubMed ID: 3858282
[TBL] [Abstract][Full Text] [Related]
33. Relationship between cell membrane potential and natural killer cell cytolysis in human hepatocellular carcinoma cells.
Stevenson D; Binggeli R; Weinstein RC; Keck JG; Lai MC; Tong MJ
Cancer Res; 1989 Sep; 49(17):4842-5. PubMed ID: 2547520
[TBL] [Abstract][Full Text] [Related]
34. Studies on the mechanism of natural killer cell-mediated cytotoxicity. V. Lack of NK specificity at the level of induction of natural killer cytotoxic factors in cultures of human, murine, or rat effector cells stimulated with mycoplasma-free cell lines.
Wright SC; Bonavida B
J Immunol; 1984 Dec; 133(6):3415-23. PubMed ID: 6491292
[TBL] [Abstract][Full Text] [Related]
35. Invariant natural killer T cells are preserved in patients with glioma and exhibit antitumor lytic activity following dendritic cell-mediated expansion.
Dhodapkar KM; Cirignano B; Chamian F; Zagzag D; Miller DC; Finlay JL; Steinman RM
Int J Cancer; 2004 May; 109(6):893-9. PubMed ID: 15027123
[TBL] [Abstract][Full Text] [Related]
36. The relationship between multi-drug resistance and resistance to natural-killer-cell and lymphokine-activated killer-cell lysis in human leukemic cell lines.
Treichel RS; Olken S
Int J Cancer; 1992 Jan; 50(2):305-10. PubMed ID: 1370437
[TBL] [Abstract][Full Text] [Related]
37. Comparison of fluorochrome-labeled and 51Cr-labeled targets for natural killer cytotoxicity assay.
Wierda WG; Mehr DS; Kim YB
J Immunol Methods; 1989 Aug; 122(1):15-24. PubMed ID: 2760476
[TBL] [Abstract][Full Text] [Related]
38. Experimental study on the treatment of intracerebral glioma xenograft with human cytokine-induced killer cells.
Wang P; Yu JP; Gao SY; An XM; Ren XB; Wang XG; Li WL
Cell Immunol; 2008; 253(1-2):59-65. PubMed ID: 18522858
[TBL] [Abstract][Full Text] [Related]
39. Sterile sorting of Leu-11a-positive cells (NK cells) using flow cytometry and the antineoplastic effects on brain tumors.
Fujiwara H; Kawamoto K; Numa Y; Matsumura H
Life Sci; 1989; 45(22):2103-7. PubMed ID: 2601565
[TBL] [Abstract][Full Text] [Related]
40. Cytolysis of mammary tumor targets by resting, interleukin-2 stimulated and in vitro cultured peripheral blood lymphocytes from breast cancer patients.
Brenner BG; McCrea EL; Margolese RG
Anticancer Res; 1988; 8(4):653-8. PubMed ID: 3263077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
